A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria

Sarbjit Saini, Karin E. Rosen, Hsin Ju Hsieh, Dennis A. Wong, Edward Conner, Allen Kaplan, Sheldon Spector, Marcus Maurer

Research output: Contribution to journal › Article › peer-review

272 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria'. Together they form a unique fingerprint.

Medicine & Life Sciences